Neurotech International Ltd
ASX:NTI
Balance Sheet
Balance Sheet Decomposition
Neurotech International Ltd
Neurotech International Ltd
Balance Sheet
Neurotech International Ltd
| Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
2
|
0
|
0
|
5
|
2
|
3
|
2
|
3
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
3
|
|
| Cash Equivalents |
0
|
0
|
2
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
2
|
10
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
3
|
3
|
1
|
0
|
5
|
2
|
5
|
12
|
3
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
5
+69%
|
5
-7%
|
1
-86%
|
0
-88%
|
5
+6 095%
|
2
-60%
|
5
+162%
|
12
+130%
|
3
-73%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-55%
|
0
-43%
|
0
-5%
|
1
+105%
|
1
+57%
|
1
-48%
|
1
+127%
|
0
-77%
|
0
-9%
|
|
| Equity | |||||||||||
| Common Stock |
4
|
10
|
14
|
15
|
15
|
26
|
26
|
34
|
47
|
49
|
|
| Retained Earnings |
2
|
6
|
10
|
15
|
16
|
22
|
24
|
30
|
35
|
45
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
1
N/A
|
4
+192%
|
4
-1%
|
0
-93%
|
1
N/A
|
4
N/A
|
1
-63%
|
4
+177%
|
12
+200%
|
3
-75%
|
|
| Total Liabilities & Equity |
3
N/A
|
5
+69%
|
5
-7%
|
1
-86%
|
0
-88%
|
5
+6 095%
|
2
-60%
|
5
+162%
|
12
+130%
|
3
-73%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
101
|
101
|
125
|
136
|
215
|
697
|
698
|
874
|
1 017
|
1 050
|
|